rs4790235
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000080.4(CHRNE):c.53G>T(p.Gly18Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0314 in 1,614,008 control chromosomes in the GnomAD database, including 2,014 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000080.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNE | ENST00000649488.2 | c.53G>T | p.Gly18Val | missense_variant | 2/12 | NM_000080.4 | ENSP00000497829.1 | |||
C17orf107 | ENST00000381365.4 | c.*2224C>A | 3_prime_UTR_variant | 3/3 | 2 | NM_001145536.2 | ENSP00000370770.3 | |||
CHRNE | ENST00000649830.1 | c.-881G>T | 5_prime_UTR_premature_start_codon_gain_variant | 2/11 | ENSP00000496907.1 | |||||
CHRNE | ENST00000649830.1 | c.-881G>T | 5_prime_UTR_variant | 2/11 | ENSP00000496907.1 |
Frequencies
GnomAD3 genomes AF: 0.0319 AC: 4852AN: 152026Hom.: 200 Cov.: 32
GnomAD3 exomes AF: 0.0487 AC: 12243AN: 251414Hom.: 1148 AF XY: 0.0412 AC XY: 5599AN XY: 135888
GnomAD4 exome AF: 0.0313 AC: 45770AN: 1461864Hom.: 1814 Cov.: 35 AF XY: 0.0298 AC XY: 21684AN XY: 727234
GnomAD4 genome AF: 0.0319 AC: 4860AN: 152144Hom.: 200 Cov.: 32 AF XY: 0.0337 AC XY: 2510AN XY: 74396
ClinVar
Submissions by phenotype
not specified Benign:5
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 15, 2013 | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 08, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 19, 2018 | p.Gly18Val in exon 2 of CHRNE: This variant is classified as benign because it h as been identified in 23% (7902/34416) of Latino chromosomes, including 1073 hom ozygous individuals, by the Genome Aggregation Database (gnomAD, http://gnomad.b roadinstitute.org; dbSNP rs4790235). - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Congenital myasthenic syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Congenital myasthenic syndrome 4A Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at